Jade Biosciences, Inc. Share Price
NASDAQ: JBIO | Small CapJade Biosciences, Inc. Stock Performance
Jade Biosciences, Inc. Share Price Today
As of 31 October 2026, Jade Biosciences, Inc.'s share price is $14.07. The stock opened at $14.17, compared to its previous close of $14.24. During today's trading session, Jade Biosciences, Inc.'s share price traded between $13.86 and $14.23, with an average price of $14.05. Over the past 52 weeks, the stock has recorded a high of $27.70 and a low of $8.79. In terms of performance, Jade Biosciences, Inc.'s share price has declined by 42.28% over the last six months and is up 43.77% on a year-on-year basis.
Jade Biosciences, Inc. Share Price Chart
Jade Biosciences, Inc. Quarterly Profit & Loss
All figures in USD
About Jade Biosciences, Inc.
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
Jade Biosciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $13.85 | $14.06 | -0.07% |
Sep 2026 | $21.55 | $14.07 | -33.97% |
Aug 2026 | $19.57 | $21.32 | +7.90% |
Jul 2026 | $22.30 | $19.75 | -11.01% |
Jun 2026 | $20.55 | $22.20 | +5.36% |
May 2026 | $24.01 | $21.07 | -13.59% |
Apr 2026 | $14.19 | $24.39 | +73.87% |
Mar 2026 | $14.81 | $14.03 | -5.36% |
Feb 2026 | $16.48 | $14.82 | -4.91% |
Jan 2026 | $15.31 | $15.59 | +1.27% |
Dec 2025 | $12.46 | $15.39 | +19.72% |
Nov 2025 | $9.54 | $12.86 | +31.31% |